Literature DB >> 20394859

Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Oncol Biol Phys 2009;73:492-498).

Thomas J Fitzgerald, Maryann Bishop-Jodoin, M Giulia Cicchetti, Richard Hanusik, Sandy Kessel, Fran Laurie, Kathleen M McCarten, Janaki Moni, Richard S Pieters, Nancy Rosen, Kenneth Ulin, Marcia Urie, Allen R Chauvenet, Louis S Constine, James Deye, Bhadrasain Vikram, Debra Friedman, Robert B Marcus, Nancy P Mendenhall, Jon L Williams, James Purdy, Joel Saltz, Cindy L Schwartz, Keith S White, Suzanne Wolden.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20394859      PMCID： PMC2908913          DOI： 10.1016/j.ijrobp.2009.12.051

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  6 in total

1.  Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.

Authors:  M A Weiner; B Leventhal; M L Brecher; R B Marcus; A Cantor; P W Gieser; J L Ternberg; F G Behm; M D Wharam; A R Chauvenet
Journal:  J Clin Oncol       Date:  1997-08       Impact factor: 44.544

2.  Processes for quality improvements in radiation oncology clinical trials.

Authors:  T J FitzGerald; Marcia Urie; Kenneth Ulin; Fran Laurie; Jeffrey Yorty; Richard Hanusik; Sandy Kessel; Maryann Bishop Jodoin; Gani Osagie; M Giulia Cicchetti; Richard Pieters; Kathleen McCarten; Nancy Rosen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008       Impact factor: 7.038

Review 3.  Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: a systematic review.

Authors:  Justin E Bekelman; Joachim Yahalom
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-09-17       Impact factor: 7.038

4.  Developing a multi-institutional PACS archive and designing processes to manage the shift from a film to a digital-based archive.

Authors:  Nicole K Laprise; Richard Hanusik; T J Fitzgerald; Nancy Rosen; Keith S White
Journal:  J Digit Imaging       Date:  2007-10-09       Impact factor: 4.056

5.  Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study.

Authors:  C K Tebbi; N Mendenhall; W B London; J L Williams; P A de Alarcon; A R Chauvenet
Journal:  Pediatr Blood Cancer       Date:  2006-02       Impact factor: 3.167

6.  A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.

Authors:  Cindy L Schwartz; Louis S Constine; Doojduen Villaluna; Wendy B London; Robert E Hutchison; Richard Sposto; Steven E Lipshultz; Charles S Turner; Pedro A deAlarcon; Allen Chauvenet
Journal:  Blood       Date:  2009-07-07       Impact factor: 22.113
  6 in total
  5 in total

Review 1.  What we have learned: the impact of quality from a clinical trials perspective.

Authors:  Thomas J FitzGerald
Journal:  Semin Radiat Oncol       Date:  2012-01       Impact factor: 5.934

2.  Radiotherapy quality assurance report from children's oncology group AHOD0031.

Authors:  Kavita V Dharmarajan; Debra L Friedman; T J FitzGerald; Kathleen M McCarten; Louis S Constine; Lu Chen; Sandy K Kessel; Matt Iandoli; Fran Laurie; Cindy L Schwartz; Suzanne L Wolden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-02-07       Impact factor: 7.038

3.  The radiotherapy quality assurance gap among phase III cancer clinical trials.

Authors:  Kelsey L Corrigan; Stephen Kry; Rebecca M Howell; Ramez Kouzy; Joseph Abi Jaoude; Roshal R Patel; Anuja Jhingran; Cullen Taniguchi; Albert C Koong; Mary Fran McAleer; Paige Nitsch; Claus Rödel; Emmanouil Fokas; Bruce D Minsky; Prajnan Das; C David Fuller; Ethan B Ludmir
Journal:  Radiother Oncol       Date:  2021-11-25       Impact factor: 6.280

4.  Credentialing for participation in clinical trials.

Authors:  David S Followill; Marcia Urie; James M Galvin; Kenneth Ulin; Ying Xiao; Thomas J Fitzgerald
Journal:  Front Oncol       Date:  2012-12-26       Impact factor: 6.244

5.  Automated Extraction of Dose/Volume Statistics for Radiotherapy-Treatment-Plan Evaluation in Clinical-Trial Quality Assurance.

Authors:  Yutao U T Gong; Jialu Yu; Dalong Pang; Heming Zhen; James Galvin; Ying Xiao
Journal:  Front Oncol       Date:  2016-03-03       Impact factor: 6.244
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.